07Dec
Private Equity Dealmakers Guidebook to Healthcare M&A During the Covid-19 Pandemic
The COVID-19 pandemic has stressed the M&A market at every stage of the deal-making process – from complicating on-site visits and intensifying the diligence process to introducing valuation gaps (relative to pre-COVID-19 expectations), complicating purchase agreement negotiations and limiting the availability of debt financing. Despite these hurdles, healthcare dealmakers have continued to pursue attractive acquisition opportunities throughout 2020, with the healthcare M&A market substantially...
By:
Bass, Berry & Sims PLC
Related
What is a Reasonable Accommodation Under the ADA? Under the Americans With Disabilities Act, as amen...
Read More >
Yesterday September 12, 2019, the California Supreme Court held that private litigants may not recov...
Read More >
You already know that ERISA regulations set specific timelines for the issuance of ERISA-governed lo...
Read More >
On July 16, 2019, three prominent whistleblower law regulators spoke at PLI’s Corporate Whistleblow...
Read More >
Seyfarth Synopsis: California employers racing to ensure all their employees receive mandatory haras...
Read More >
Does the way you communicate affect whether others trust you? Much, much more than you realize. In t...
Read More >